Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/19533023

Download in:

View as

General Info

PMID
19533023